Post-burn multiple organ dysfunction, SIRS, and bacterial translocation

Overview¶

Multiple organ dysfunction is what kills burn patients who survive the first days. Sepsis is the leading cause of death in burn patients ^[1], and it acts largely through organ failure. Across a European systematic review, multiple organ failure and sepsis were the most frequently reported causes of death overall, while burn shock and inhalation injury accounted for the earliest deaths (under 48 hours) ^[25]. Among Dutch burn deaths, multiple organ failure was the single most common cause of late mortality ^[19], and in a Catalan cohort multiorgan failure caused nearly half of all in-hospital deaths ^[22]. The syndrome is the final common pathway: severe burn initiates a cascade of downstream events that culminates in organ dysfunction, sepsis, and death ^[4].

The clinical problem is that organ failure after a burn is not one disease but two overlapping ones. An early, often sterile wave is driven by the burn-induced inflammatory and hypermetabolic response itself; a later wave is driven by secondary infection in an immunosuppressed host ^[6]. Both converge on the same end organs (kidney, lung, liver, heart, marrow, gut) and the same scoring tools, but they differ in timing, mechanism, and what a clinician can do about them. This page covers who is at risk, the two-hit pathophysiology including the contested gut hypothesis, how dysfunction is measured, what organ support and response-modulating strategies the evidence supports, and where the evidence runs out.

Epidemiology¶

How often organ failure follows a burn depends heavily on burn severity and how failure is defined, but the burden is substantial across populations. In a series of ventilator-supported major burns with a mean burn size of 61% TBSA, just over half of patients developed early MODS ^[18]. In an Albanian cohort the incidence of multiple organ dysfunction reached 63% and overt multiple organ failure 37% ^[17], and a U.S. pediatric ICU study across 117 units found multiple organ failure in roughly a quarter of burn-injured children ^[20]. A separate adult cohort identified multiple organ failure in 27% of patients during the study period ^[15]. The numbers vary because thresholds vary, but organ dysfunction is common, not exceptional, in the severely burned.

Burn size is the dominant risk factor. Modern burn-care data establish that adults with over 40% TBSA burned and children with over 60% TBSA are at high risk for morbidity and mortality, including sepsis and multiple organ failure, even in highly specialized centers ^[16]. The same large multicenter analysis fixed the burn-size cutoff for mortality, sepsis, infection, and multiple organ failure at approximately 60% TBSA in children and 40% in adults ^[16]. A meta-analysis of acute kidney injury reinforced the dose-response, finding total burn surface area among the strongest independent predictors of AKI ^[11].

Age and inhalation injury compound burn size. Older age and larger burned surface area, along with chronic disease, are the major risk factors for death, which typically results from multisystem organ failure and sepsis ^{[19] [13]}. Burn-induced immune dysregulation is implicated as the mechanistic link between these risk factors and lethal organ failure ^[13]. Inhalation injury is present in roughly a third of large burns and independently raises the risk of MODS and overall mortality ^[14]; in one cohort it was significantly associated with development of MOF in the acute phase, with an adjusted odds ratio of about 3 ^[15]. Sepsis sits both upstream and downstream: it is among the strongest risk factors for AKI ^[11], and burn patients carry a higher prevalence of sepsis and worse sepsis-associated mortality than general trauma or critical-care populations ^[24].

Pathophysiology¶

The two-hit model¶

The governing framework is a two-hit sequence. The first hit is the burn itself: major thermal injury generates a marked pathophysiological inflammatory response through widespread release of pro-inflammatory mediators, predisposing to systemic inflammatory response syndrome, sepsis, and multiorgan failure ^[2]. This is layered onto a profound hypermetabolic response; burn-induced inflammation and the subsequent hypermetabolic state can drive profound infection and sepsis, resulting in multiple organ failure and high mortality ^[8]. The second hit is typically secondary infection in an immunocompromised host; sepsis is the leading cause of death in burns and acts largely by tipping already-stressed organs into failure ^[1]. Importantly, the inflammatory response to burns is not a linear escalation but an unstable equilibrium between pro- and anti-inflammatory forces, where outcome is determined less by the initial magnitude of cytokine release than by the persistence of dysregulated inflammation or the failure of compensatory mechanisms ^[6]. When this balance fails it produces immune dysregulation, including apoptosis-driven lymphopenia and impaired phagocytosis, that favors lethal infectious complications ^[82].

Cytokine storm and endothelial injury¶

Excessive systemic inflammation is the proximate driver of distant organ injury ^[6], and the burn inflammatory response is increasingly understood as a systemic, multi-axis process including a CNS-spleen neuroimmune axis that shapes how burn patients mount and resolve it ^[8]. Interleukin-6 rises threefold after large burns, particularly with bacteremia, and correlates with poor clinical outcome ^[80], and interleukin-8 is elevated after thermal injury and higher still in patients who progress to sepsis ^[81]. The inflammatory cascade injures the endothelium directly: degradation of the endothelial glycocalyx promotes systemic inflammation, vascular instability, and multiorgan failure ^[95], and circulating histones released from dying tissue cause endothelial barrier dysfunction and microvascular leakage through the endothelial Clec2d receptor ^[38]. NET-derived chromatin and cell-free DNA are elevated after severe burns and trauma and associate with poor outcome, marking the link between neutrophil hyperactivation, coagulopathy, and organ injury ^[41]. Burn-induced coagulopathy, with early hypercoagulability followed by hypocoagulation, has itself been associated with MODS and death ^[79].

Ischemia-reperfusion and the gut hypothesis¶

After a major burn the gastrointestinal tract becomes hypoxic from fluid loss and reduced intestinal blood flow, perturbing the epithelial barrier, immune function, and the gut microbiome ^[51]. The gut hypothesis proposes that this barrier failure allows bacteria and endotoxin to cross into the lymphatics and bloodstream, driving distant organ injury. Mechanistically, increased gut permeability generates proinflammatory signaling that further damages the barrier in a feed-forward loop ^[51], and the gastrointestinal microbiome is now recognized as a regulator of the post-burn immune response that can also contribute to sepsis and multiple organ failure through dysbiosis ^[45]. Human studies document the permeability defect: intestinal permeability measured by lactulose-mannitol or sucrose excretion rises sharply on the first post-burn day ^{[47] [48]}, and translocational endotoxemia appears in the circulation early after injury ^[49]. Whether this translocation causes organ failure in humans, or merely accompanies it, is the central controversy of this topic and is taken up below.

The alcohol-burn literature is where the translocation mechanism is best dissected, almost entirely in animal models. Ethanol intoxication at the time of burn worsens intestinal dysfunction, downregulates the antimicrobial peptide REG3G, and facilitates bacterial translocation from gut to mesenteric lymph nodes and the systemic circulation ^{[40] [42]}; intestine-specific REG3G overexpression reverses these effects and reduces translocation and liver inflammation ^[40]. A parallel mechanism implicates platelet-activating factor carried on keratinocyte microvesicle particles, which act on the gut to activate myosin light chain kinase, breach the barrier, and produce the multiorgan dysfunction of intoxicated burn injury ^{[39] [43]}. These are coherent and reproducible in mice, but they remain preclinical.

Immunosuppression and persistent inflammation¶

The host that survives the first hit is left immunosuppressed. Burn-induced immunosuppression includes apoptosis-driven lymphopenia, decreased IL-2 secretion, impaired phagocytosis, and reduced monocyte HLA-DR expression ^[82]. Severe injury induces a persistent innate inflammatory response, including release of immature neutrophils and a shift toward a pro-inflammatory T-cell phenotype, sustaining systemic inflammation and raising the risk of secondary complications ^[83]. In some patients this evolves into chronic critical illness with dysregulated immune responses ^[84]. This combination, simultaneous hyperinflammation and immune exhaustion, is why the same patient can be both inflamed and unable to clear infection.

Assessment¶

Assessing organ dysfunction in burns means watching organ-specific function over time, because the vital-sign triggers that work elsewhere fail here. By definition a patient with an extensive burn already meets SIRS criteria from the injury alone ^[26], and traditional SIRS criteria do not aid the diagnosis of sepsis in burn centers ^[28]. In one validation cohort SIRS criteria flagged 98% of subjects, making them non-discriminative ^[27], and SIRS score at admission was not independently predictive of poor outcome on multivariable analysis ^[85].

Organ-dysfunction scoring carries more weight than vital-sign triggers. The Sequential Organ Failure Assessment (SOFA) and the Denver multiple-organ-failure score quantify dysfunction across systems; MOF has been operationally defined by the coexistence of acute kidney injury and ARDS (P/F ratio under 300) ^[32]. The trajectory matters more than any single value: in a burn cohort, the change in SOFA between day 0 and day 3 was significantly associated with mortality after adjustment for age and TBSA, and the delta-SOFA outperformed the day-0 score for predicting death (AUC 0.83 versus 0.79) ^[21]. Subsystem-specific analysis points to particular signals: a temporal biomarker study identified creatinine elevation and thrombocytopenia as the key organ-specific SOFA indicators in burn sepsis, with renal, cardiovascular, and coagulation subsystems showing the highest diagnostic specificity ^[31].

Biomarkers add information but no single one is a standard. Procalcitonin is the most-studied marker, moderately sensitive and specific for sepsis in burns ^[33], with meta-analyses placing its summary AUC around 0.83-0.88 for early burn-sepsis diagnosis ^{[10] [35]}; deceased burn patients carry higher procalcitonin, CRP, and neutrophil-to-lymphocyte ratios than survivors ^[7]. Newer markers are emerging for organ-failure prediction specifically: mid-regional pro-adrenomedullin rises the day before sepsis diagnosis and tracks SOFA severity ^[36], and in a smoke-inhalation-and-burn swine model an HMGB1 rise at 12 hours predicted later AKI and MOF (AUROC 0.89) ^[32]. Mitochondrial DNA and cell-free DNA are elevated in septic burn patients and proposed as MODS biomarkers ^{[37] [41]}, and neutrophil CD64 carries good diagnostic value for burn infection in pooled analysis ^[34]. These remain single-study or preclinical signals, not validated bedside tests.

Management¶

No treatment reverses established multiple organ dysfunction. Management is supportive and preventive: control the source, resuscitate to physiologic endpoints without overshooting, support failing organs, and modulate the inflammatory drive where evidence allows. The two-hit model frames the strategy, since preventing the second hit (infection) is more tractable than reversing the first.

Source control and resuscitation balance¶

Early excision and grafting limits the inflammatory burden that feeds organ failure. A meta-analysis found a significant mortality reduction with early excision compared with traditional treatment in patients without inhalation injury ^[86], and skin grafting significantly reduced the risk of infectious complications and SIRS development in pediatric burns ^[88]. Resuscitation is a balance: under-resuscitation drives early organ ischemia while over-resuscitation worsens edema and abdominal compartment pressure. Hemodynamic-guided resuscitation has been compared with urine-output targeting with conflicting results across studies, and randomized trials alone showed no clear survival advantage of one endpoint over the other ^[87].

Organ support¶

When organs fail, support buys time. For burn-associated AKI, renal replacement therapy is used in roughly 8-16% of ICU burns ^[12]; the optimal timing is unsettled, with a retrospective cohort finding delayed initiation gave survival similar to early initiation ^[77]. Extracorporeal blood purification has been studied to remove inflammatory mediators: continuous renal replacement therapy lowers plasma endotoxin and cytokines (TNF-alpha, IL-1beta, IL-6, IL-8) in septic burn patients ^{[63] [64]}, and a meta-analysis reported reduced mortality and sepsis with blood purification in deep burns ^[61]. A randomized trial of high-volume hemofiltration in burn septic shock with AKI improved organ function and reversed shock without a demonstrated survival difference ^[62], and adjunctive cytokine adsorption (CytoSorb) was associated with lower mortality in burn septic shock poorly responsive to standard CRRT in an observational comparison ^[78]. For lung failure, lung-protective support is standard ICU practice; the evidence here characterizes the burden (early ARDS within 7 days of injury) rather than burn-specific ventilation trials.

Modulating the response¶

Several strategies aim at the inflammatory and hypermetabolic drive. Propranolol blunts hypermetabolism: it does not increase infection or sepsis in severely burned children ^[66], lowers resting energy expenditure in adults without raising the rate of multiple organ failure or death ^[67], and a meta-analysis found beta-blockade reduces length of stay and cardiac burden without increasing mortality or sepsis ^[68]. Anti-inflammatory adjuncts show mechanistic signals: omega-3 polyunsaturated fatty acids reduced the incidence of severe sepsis, septic shock, and MODS in a meta-analysis, though trial-sequential analysis judged the evidence inconclusive and 14-day mortality unchanged ^[60]. Cell-based approaches remain experimental; mesenchymal stem cell treatment attenuated liver and lung inflammation after combined ethanol and burn injury in a preclinical model ^[3]. Antithrombin administration in the acute phase reduced MOF incidence and 28-day mortality in one study ^[65]. Nutrition is foundational: early enteral nutrition significantly reduced mortality (OR 0.36), sepsis, pneumonia, and renal failure in a meta-analysis of randomized trials, with preserved gut integrity as the proposed mechanism ^[52]; enteral nutrition lowered burn-sepsis incidence compared with parenteral nutrition in early post-burn care ^[54], and higher energy delivery was associated with improved 6-month survival ^[69].

Gut-directed strategies¶

The gut hypothesis has motivated decades of attempts to protect the barrier or decontaminate the lumen, with mixed results. Selective decontamination of the digestive tract (SDD) reduced ICU and hospital mortality in a randomized placebo-controlled burn trial ^[57] and attenuated organ dysfunction, particularly respiratory and hematological, in another ^[56]; but a pediatric trial found no benefit ^[58], and a 2025 systematic review concluded the certainty of evidence for SDD on patient-important outcomes in burns is very low ^[55]. Enteral glutamine improved gut permeability and reduced endotoxemia ^[48] and reduced bloodstream infection threefold in one trial ^[53], though a meta-analysis found it may not improve mortality ^[89]. Probiotics reduced infection rate and raised serum IgA in a systematic review but did not change sepsis rate or mortality ^[59], and their use is tempered by concern for translocation and infection in immunocompromised hosts ^[90]. The recurring pattern is a reduction in infectious surrogates without a reliable mortality signal.

Complications¶

The organ-specific complications of MODS define its clinical face. Acute kidney injury is the most studied: pooled incidence among ICU burns is roughly 30-40% ^{[11] [12]}, AKI patients have markedly longer ICU stays and far higher mortality (odds ratio for death over 11 in one meta-analysis) ^[12], and the mechanism splits by timing. Early AKI reflects reduced cardiac output from fluid loss, rhabdomyolysis, or hemolysis; late AKI is usually a consequence of sepsis and is associated with multiorgan failure ^[91]. The lung fails early and often, with ARDS appearing within the first week in nearly all of one ventilated cohort and a P/F nadir around day 5 ^[92]. Cardiac dysfunction is the highest-incidence organ failure across hospital stay in one pediatric analysis, and non-occlusive acute mesenteric ischemia clusters with low early cardiac output and early MODS ^{[93] [94]}. Liver dysfunction is the second most common organ failure; bedside perfusion monitoring detects it earlier than static markers, and most cases recover within 48 hours ^[23]. Hematologic dysfunction, including disseminated intravascular coagulation, accompanies severe injury and burn-induced coagulopathy ^[79].

Across these systems, the number of failing organs is the prognostic spine. Multiple organ failure was the most frequent cause of death in a Catalan cohort (49.5%) ^[22], the leading cause of death in burn patients requiring ICU admission in another ^[21], and the main cause of death in up to 40% of cases in a recent series, where length of ICU stay scaled with severity of organ failure ^[23]. Sepsis and MODS are intertwined: sepsis is mostly caused by, and causes, multiple organ failure, making it the most dangerous complication of burns ^[81]. Infections account for roughly three-quarters of burn-related fatalities ^[75].

Special Considerations¶

Age modifies the syndrome. Elderly burn patients have profoundly increased mortality and, notably, develop more multiple organ failure without a higher incidence of infection or sepsis, pointing to an intrinsic vulnerability of aged organs rather than greater infection burden ^[70]. Mechanistically, aged hepatic mitochondria fail to normalize after injury, and elderly patients show more obvious early injury to heart, liver, kidney, lung, and coagulation at the same level of tissue perfusion as younger patients ^{[5] [72]}. The pediatric picture differs by burn-size threshold (60% TBSA rather than 40%) ^[16], and children carry distinct risks including thermal-injury-associated toxic shock syndrome, which carries high mortality and morbidity ^[74]. Pediatric data also show a greater independent risk of multiple organ failure in some cohorts and a sex dimorphism in outcome ^[71].

Inhalation injury deserves separate emphasis because its contribution to MODS is not simply additive inflammation. In severely burned children, inhalation injury did not augment the systemic inflammatory response yet still carried roughly threefold higher mortality than non-inhalation injury (40% versus 12%) in one series ^[73]. Alcohol intoxication at the time of injury is a distinct risk multiplier: nearly half of U.S. burn patients are intoxicated at injury, and intoxication worsens systemic inflammation, gut barrier failure, and bacterial translocation ^{[40] [42]}. These populations decompensate faster and merit a lower threshold for organ-support escalation.

Outcomes¶

Outcome in post-burn MODS is governed by how many organs fail and how the burn-size, age, and inhalation-injury triad stacks. Mortality scales with organ-failure count, and multiple organ failure is repeatedly the leading or most frequent cause of late death across cohorts ^{[19] [22] [25]}. Burn patients carry worse sepsis-associated mortality (28-65%) than trauma or general critical-care populations ^[24]. The composite of organ dysfunction plus death has been proposed as a trial endpoint precisely because organ failure is such a reliable mortality surrogate in this population.

Recovery is possible when the precipitating hit is controlled. Liver dysfunction recovered within 48 hours in three-quarters of one cohort ^[23], and early-ARDS mortality was under 10% when the lung was the dominant failure ^[92]. The prognostic tools (SOFA trajectory, revised Baux, Denver score) stratify risk well but do not change the fundamental driver: the page-level message is that prevention of the second hit and timely organ support, not any single drug, determine survival.

Controversies and Evidence Gaps¶

The unsettled questions here are mechanistic and therapeutic, not peripheral.

• Does gut translocation cause human MODS, or is it an epiphenomenon? This is the field's central debate. The barrier defect and early endotoxemia are real and measurable in humans ^{[47] [50]}, and translocation drives organ injury convincingly in animal models ^{[40] [43]}. But the causal step in humans is unproven: an early human study titled its central question "Translocation: incidental phenomenon or true pathology?" and found that reducing plasma endotoxin with polymyxin B did not change the cytokine cascade or mortality, concluding that SIRS is driven by injury-induced cytokine induction and is unaffected by endotoxin reduction ^[49]. The role of microbial dysbiosis in exacerbating acute injury such as burn remains poorly understood ^[49].
• Selective decontamination of the digestive tract is unresolved. Individual trials show mortality and organ-dysfunction benefit ^{[57] [56]}, yet a pediatric trial found none ^[58] and a 2025 systematic review rated the certainty of evidence as very low across patient-important outcomes ^[55]. SDD has not entered routine burn practice despite decades of study.
• Antibiotic and decontamination effects on translocation are paradoxical. In one model, broad-spectrum antibiotics promoted bacterial translocation in burned rats but prevented it in septic rats, complicating any simple decontamination rationale ^[76].
• Immunonutrition and antioxidants show signals without confirmed mortality benefit. Omega-3 PUFAs reduced sepsis and MODS incidence but trial-sequential analysis judged the evidence inconclusive ^[60]; glutamine and probiotics reduce infectious surrogates without reliable mortality effect ^{[89] [59]}.
• No biomarker or score is a validated MODS-prediction standard. Procalcitonin, mtDNA, HMGB1, MR-proADM, and cell-free DNA each show promise in single studies or animal models, but none is established for routine organ-failure prediction at the bedside ^{[34] [36] [32]}.
• SIRS-based assessment is inadequate in burns and not yet fully replaced. Traditional SIRS criteria do not discriminate, and the Sepsis-3 organ-dysfunction framework did not show superior prognostic accuracy for mortality in severely burned patients ^[29]. Organ-dysfunction trajectory (SOFA evolution, subsystem-specific signals) is the more promising direction, but a unified, validated burn-MODS framework is not yet in place ^{[27] [28] [31]}.

References¶

[1] Manning J. "Sepsis in the Burn Patient." Critical care nursing clinics of North America 2018. PMID: 30098746 ↩

[2] Kim A, Lang T, Xue M, Wijewardana A, Jackson C, Vandervord J. "The Role of Th-17 Cells and γδ T-Cells in Modulating the Systemic Inflammatory Response to Severe Burn Injury." International journal of molecular sciences 2017. PMID: 28368347 ↩

[3] Curtis BJ, Shults JA, Boe DM, Ramirez L, Kovacs EJ. "Mesenchymal stem cell treatment attenuates liver and lung inflammation after ethanol intoxication and burn injury." Alcohol (Fayetteville, N.Y.) 2019. PMID: 30217504 ↩

[4] van Langeveld I, et al. "Multiple-Drug Resistance in Burn Patients: A Retrospective Study on the Impact of Antibiotic Resistance on Survival and Length of Stay." Journal of burn care & research : official publication of the American Burn Association 2017. PMID: 27984411 ↩

[5] Auger C, Sivayoganathan T, Abdullahi A, Parousis A, Jeschke MG. "Hepatic mitochondrial bioenergetics in aged C57BL/6 mice exhibit delayed recovery from severe burn injury." Biochimica et biophysica acta. Molecular basis of disease 2017. PMID: 28711594 ↩

[6] Constantinescu MC, et al. "Variation of Pro- and Anti-Inflammatory Factors in Severe Burns: A Systematic Review." International journal of molecular sciences 2025. PMID: 41155423 ↩

[7] Nourigheimasi S, et al. "Association of inflammatory biomarkers with overall survival in burn patients: a systematic review and meta-analysis." BMC emergency medicine 2024. PMID: 38684973 ↩

[8] Khan N, Kaur S, Knuth CM, Jeschke MG. "CNS-Spleen Axis - a Close Interplay in Mediating Inflammatory Responses in Burn Patients and a Key to Novel Burn Therapeutics." Frontiers in immunology 2021. PMID: 34539655 ↩

[9] He Y, Luo L, Liu L. "Photodynamic therapy for treatment of burns: A system review and meta-analysis of animal study." Photodiagnosis and photodynamic therapy 2024. PMID: 38013017

[10] Cabral L, Afreixo V, Almeida L, Paiva JA. "The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis." PloS one 2016. PMID: 28005932 ↩

[11] Wu G, et al. "Risk Factors for Acute Kidney Injury in Patients With Burn Injury: A Meta-Analysis and Systematic Review." Journal of burn care & research : official publication of the American Burn Association 2017. PMID: 27617407 ↩

[12] Folkestad T, et al. "Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysis." Critical care (London, England) 2020. PMID: 31898523 ↩

[13] Sood RF, et al. "Early leukocyte gene expression associated with age, burn size, and inhalation injury in severely burned adults." The journal of trauma and acute care surgery 2016. PMID: 26517785 ↩

[14] Sutton T, Lenk I, Conrad P, Halerz M, Mosier M. "Severity of Inhalation Injury is Predictive of Alterations in Gas Exchange and Worsened Clinical Outcomes." Journal of burn care & research : official publication of the American Burn Association 2017. PMID: 28570316 ↩

[15] Ogura A, et al. "Associations between clinical characteristics and the development of multiple organ failure after severe burns in adult patients." Burns : journal of the International Society for Burn Injuries 2019. PMID: 31690472 ↩

[16] Jeschke MG, et al. "Morbidity and survival probability in burn patients in modern burn care." Critical care medicine 2015. PMID: 25559438 ↩

[17] Belba MK, Petrela EY, Belba AG. "Epidemiology and outcome analysis of sepsis and organ dysfunction/failure after burns." Burns : journal of the International Society for Burn Injuries 2017. PMID: 28545914 ↩

[18] Feng JY, et al. "Predictors of Early Onset Multiple Organ Dysfunction in Major Burn Patients with Ventilator Support: Experience from A Mass Casualty Explosion." Scientific reports 2018. PMID: 30026512 ↩

[19] Dokter J, et al. "Mortality and causes of death of Dutch burn patients during the period 2006-2011." Burns : journal of the International Society for Burn Injuries 2015. PMID: 25481974 ↩

[20] McCrory MC, Woodruff AG, Saha AK, Halvorson EE, Critcher BM, Holmes JH. "Characteristics of Burn-Injured Children in 117 U.S. PICUs (2009-2017): A Retrospective Virtual Pediatric Systems Database Study." Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2021. PMID: 33689253 ↩

[21] Calles J, et al. "Variation of the SOFA score and mortality in patients with severe burns: A cohort study." Burns : journal of the International Society for Burn Injuries 2023. PMID: 36202683 ↩

[22] Abarca L, Guilabert P, Martin N, Usúa G, Barret JP, Colomina MJ. "Epidemiology and mortality in patients hospitalized for burns in Catalonia, Spain." Scientific reports 2023. PMID: 37658072 ↩

[23] Kruse M, et al. "Detection of Liver Dysfunction in Severe Burn Injury with Bedside Measurement of Perfusion." Medicina (Kaunas, Lithuania) 2026. PMID: 41901551 ↩

[24] Mann EA, Baun MM, Meininger JC, Wade CE. "Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature." Shock (Augusta, Ga.) 2012. PMID: 21941222 ↩

[25] Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. "Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality." Critical care (London, England) 2010. PMID: 20958968 ↩

[26] Greenhalgh DG, et al. "American Burn Association consensus conference to define sepsis and infection in burns." Journal of burn care & research : official publication of the American Burn Association 2007. PMID: 17925660 ↩

[27] Mann-Salinas EA, et al. "Novel predictors of sepsis outperform the American Burn Association sepsis criteria in the burn intensive care unit patient." Journal of burn care & research : official publication of the American Burn Association 2013. PMID: 23135212 ↩

[28] Hill DM, et al. "Predictors for Identifying Burn Sepsis and Performance vs Existing Criteria." Journal of burn care & research : official publication of the American Burn Association 2018. PMID: 29771353 ↩

[29] Yoon J, et al. "Comparative Usefulness of Sepsis-3, Burn Sepsis, and Conventional Sepsis Criteria in Patients With Major Burns." Critical care medicine 2018. PMID: 29620554 ↩

[30] Yan J, Hill WF, Rehou S, Pinto R, Shahrokhi S, Jeschke MG. "Sepsis criteria versus clinical diagnosis of sepsis in burn patients: A validation of current sepsis scores." Surgery 2018. PMID: 30049483

[31] Su H, Yuan B, Liu Y, Xi W, Qiao L. "Discriminative power of organ-specific SOFA assessment in burn sepsis: A temporal biomarker analysis." Burns : journal of the International Society for Burn Injuries 2026. PMID: 41297233 ↩

[32] Yang Z, et al. "An early HMGB1 rise 12 hours before creatinine predicts acute kidney injury and multiple organ failure in a smoke inhalation and burn swine model." Frontiers in immunology 2024. PMID: 39534595 ↩

[33] Li AT, et al. "Biomarkers for the Early Diagnosis of Sepsis in Burns: Systematic Review and Meta-analysis." Annals of surgery 2022. PMID: 35261389 ↩

[34] Chen Z, Nurlan T, Ning F, Zha T, Liu X. "Diagnostic Value of Neutrophil CD64 in Burn Patients With Infection in Chinese Population: A Systematic Review and Meta-analysis." Journal of burn care & research : official publication of the American Burn Association 2021. PMID: 33625516 ↩

[35] Zhang YJ, Guo ZH, Ming ZG, Hao ZM, Duan P. "Meta-analysis of the diagnostic value of serum procalcitonin for burn sepsis in adults." European review for medical and pharmacological sciences 2023. PMID: 37606129 ↩

[36] Flores E, et al. "Usefulness of mid-regional proadrenomedullin levels in the resuscitation phase of severely burned patients and its utility in early sepsis detection." Burns : journal of the International Society for Burn Injuries 2024. PMID: 38570251 ↩

[37] Robles MC, et al. "DIAGNOSTIC VALUE OF MITOCHONDRIAL DNA AND PERIPHERAL BLOOD MONONUCLEAR CELL RESPIROMETRY FOR BURN-RELATED SEPSIS." Shock (Augusta, Ga.) 2023. PMID: 36730861 ↩

[38] Yang X, et al. "C-TYPE LECTIN-2D RECEPTOR CONTRIBUTES TO HISTONE-INDUCED VASCULAR BARRIER DYSFUNCTION DURING BURN INJURY." Shock (Augusta, Ga.) 2024. PMID: 37878490 ↩

[39] Rohan CJ, Lohade RP, Brewer C, Travers JB. "Platelet-activating factor and microvesicle particles as potential mediators for the toxicity associated with intoxicated thermal burn injury." BioFactors (Oxford, England) 2022. PMID: 36342751 ↩

[40] McMahan RH, et al. "Intestinal REG3G Protects Against Gastrointestinal Dysfunction in a Murine Model of Ethanol Intoxication and Burn Injury." Shock (Augusta, Ga.) 2026. PMID: 41166162 ↩

[41] Asiri A, Hazeldine J, Moiemen N, Sakuma M, Irimia D, Harrison P. "Qualitative and Quantitative Analysis of Circulating Net-Derived Chromatin and Nucleosomes in Severe Thermal and Traumatically Injured Patients." Shock (Augusta, Ga.) 2026. PMID: 42059827 ↩

[42] McMahan RH, Evans MR, Najarro KM, Frank DN, Basak JM, Kovacs EJ. "Ethanol exacerbates post-burn neuroinflammation and gut-brain barrier dysfunction which are associated with microbiome changes." Alcohol (Fayetteville, N.Y.) 2026. PMID: 42066822 ↩

[43] Lohade RP, et al. "Evidence that keratinocyte microvesicle particles carrying platelet-activating factor mediate the widespread multiorgan damage associated with intoxicated thermal burn injury." Journal of leukocyte biology 2024. PMID: 38531065 ↩

[44] Costantini TW, Coimbra R, Weaver JL, Eliceiri BP. "Precision targeting of the vagal anti-inflammatory pathway attenuates the systemic inflammatory response to burn injury." The journal of trauma and acute care surgery 2022. PMID: 34789702

[45] Luck ME, Herrnreiter CJ, Choudhry MA. "Gut Microbial Changes and their Contribution to Post-Burn Pathology." Shock (Augusta, Ga.) 2021. PMID: 33481548 ↩

[46] Hajialibabaei R, Sayeli FG, Aghadavood E, Poudineh M, Khaledi A, Bamneshin K. "The beneficial role of probiotics and gut microbiota in signaling pathways, immunity, apoptosis, autophagy, and intestinal barrier for effective wound healing post-burn injury." Microbial pathogenesis 2025. PMID: 40541747

[47] Olguin F, et al. "Prebiotic ingestion does not improve gastrointestinal barrier function in burn patients." Burns : journal of the International Society for Burn Injuries 2005. PMID: 15896512 ↩

[48] Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D. "The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial." JPEN. Journal of parenteral and enteral nutrition 2003. PMID: 12903886 ↩

[49] Munster AM, Smith-Meek M, Dickerson C, Winchurch RA. "Translocation. Incidental phenomenon or true pathology?." Annals of surgery 1993. PMID: 8373274 ↩

[50] Fu W, Xiao G, Yu P. "[Changes of circulating Lps and cytokines in burned patients after anti-endotoxin therapy]." Zhonghua yi xue za zhi 1996. PMID: 9206199 ↩

[51] Luck ME, Li X, Herrnreiter CJ, Cannon AR, Choudhry MA. "IL-27 Promotes Intestinal Barrier Integrity following Ethanol Intoxication and Burn Injury." ImmunoHorizons 2022. PMID: 35973751 ↩

[52] Pu H, Doig GS, Heighes PT, Allingstrup MJ. "Early Enteral Nutrition Reduces Mortality and Improves Other Key Outcomes in Patients With Major Burn Injury: A Meta-Analysis of Randomized Controlled Trials." Critical care medicine 2018. PMID: 30222632 ↩

[53] Kibor DK, Nyaim OE, Wanjeri K. "EFFECTS OF ENTERAL GLUTAMINE SUPPLEMENTATION ON REDUCTION OF INFECTION IN ADULT PATIENTS WITH SEVERE BURNS." East African medical journal 2014. PMID: 26862634 ↩

[54] Chen ZY, Gu CZ, Wang SL, Yu B, Wang SL. "[Comparative study on the enteral and parenteral nutrition during early postburn stage in burn patients]." Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 2004. PMID: 15447821 ↩

[55] Tsuchiya EA, et al. "Selective decontamination of the digestive tract in burn patients: A systematic review with meta-analysis." Burns : journal of the International Society for Burn Injuries 2025. PMID: 40250196 ↩

[56] López-Rodríguez L, et al. "Selective Digestive Decontamination Attenuates Organ Dysfunction in Critically Ill Burn Patients." Shock (Augusta, Ga.) 2016. PMID: 27755474 ↩

[57] de La Cal MA, et al. "Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial." Annals of surgery 2005. PMID: 15729064 ↩

[58] Barret JP, Jeschke MG, Herndon DN. "Selective decontamination of the digestive tract in severely burned pediatric patients." Burns : journal of the International Society for Burn Injuries 2001. PMID: 11451595 ↩

[59] Thiagarajan AB, Narloch K, Chernyak M, Rojek NW, Sharma AN, Horton L. "Probiotic and prebiotic interventions in burn patients: A systematic review." Burns : journal of the International Society for Burn Injuries 2026. PMID: 41707541 ↩

[60] Zhou YY, Wang Y, Wang L, Jiang H. "The efficacy of Omega-3 polyunsaturated fatty acids for severe burn patients: A systematic review and trial sequential meta-analysis of randomized controlled trials." Clinical nutrition ESPEN 2024. PMID: 38220365 ↩

[61] Zhang G, Liu W, Li J, Wang D, Duan J, Luo H. "Efficacy and safety of blood purification in the treatment of deep burns: A systematic review and meta-analysis." Medicine 2021. PMID: 33592850 ↩

[62] Chung KK, et al. "High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial." Critical care (London, England) 2017. PMID: 29178943 ↩

[63] Li HB, Peng YZ. "[The influence of continuous renal replacement therapy on the plasma levels of endotoxin and cytokines in severely burned patients with sepsis]." Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 2003. PMID: 12812627 ↩

[64] Peng Y, Yuan Z, Li H. "Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis." Burns : journal of the International Society for Burn Injuries 2005. PMID: 15975721 ↩

[65] Lavrentieva A, et al. "The efficacy of antithrombin administration in the acute phase of burn injury." Thrombosis and haemostasis 2008. PMID: 18690349 ↩

[66] Jeschke MG, Norbury WB, Finnerty CC, Branski LK, Herndon DN. "Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children." The Journal of trauma 2007. PMID: 17414346 ↩

[67] Lam NN, Khanh PQ, An NH. "The use of propranolol in adult burn patients: Safety and outcome influence." Burns : journal of the International Society for Burn Injuries 2022. PMID: 34895792 ↩

[68] Ma J, et al. "The effectiveness and safety of beta antagonist in burned patients: A systematic review and meta-analysis." International wound journal 2020. PMID: 32820612 ↩

[69] Stewart BT, et al. "Higher energy delivery is associated with improved long-term survival among adults with major burn injury: A multicenter, multinational, observational study." The journal of trauma and acute care surgery 2024. PMID: 39225723 ↩

[70] Jeschke MG, et al. "Pathophysiologic Response to Burns in the Elderly." EBioMedicine 2015. PMID: 26629550 ↩

[71] Summers JI, Ziembicki JA, Corcos AC, Peitzman AB, Billiar TR, Sperry JL. "Characterization of sex dimorphism following severe thermal injury." Journal of burn care & research : official publication of the American Burn Association 2014. PMID: 24823341 ↩

[72] Wang WW, et al. "[Retrospective study on the characteristics of early organ injury in elderly patients with severe burns]." Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 2019. PMID: 30897861 ↩

[73] Finnerty CC, Herndon DN, Jeschke MG. "Inhalation injury in severely burned children does not augment the systemic inflammatory response." Critical care (London, England) 2007. PMID: 17306027 ↩

[74] Alrasheed MF, et al. "The Epidemiology of Pediatric Thermal Injury-associated Toxic Shock Syndrome: A Systematic Review." Journal of burn care & research : official publication of the American Burn Association 2024. PMID: 39039892 ↩

[75] Karna SLR, et al. "Silver sulfadiazine-cerium nitrate burn wound foam dressing stabilizes eschar by reducing local inflammation and controlling burn wound infections." Burns : journal of the International Society for Burn Injuries 2026. PMID: 41980582 ↩

[76] Wen ZL, Zhang LD, Liu SZ, Liu J, Chen YZ, Chen DC. "Effect of broad-spectrum antibiotics on bacterial translocation in burned or septic rats." Chinese medical journal 2019. PMID: 31140989 ↩

[77] Heng X, Li H. "Timing of Renal Replacement Therapy in Burn Patients With Acute Kidney Injury: A Retrospective Cohort Study." Annals of plastic surgery 2025. PMID: 39652843 ↩

[78] Mariano F, et al. "CytoSorb® in burn patients with septic shock and Acute Kidney Injury on Continuous Kidney Replacement Therapy is associated with improved clinical outcome and survival." Burns : journal of the International Society for Burn Injuries 2024. PMID: 38494395 ↩

[79] McDonough MM, et al. "A natural history study of coagulopathy in a porcine 40% total body surface area burn model reveals the time-dependent significance of functional assays." Burns : journal of the International Society for Burn Injuries 2022. PMID: 36116993 ↩

[80] Papini RP, Wilson AP, Steer JA, Hill G, McGrouther DA, Parkhouse N. "Plasma concentrations of tumour necrosis factor-alpha and interleukin-6 during burn wound surgery or dressing." British journal of plastic surgery 1997. PMID: 9245870 ↩

[81] Al-Ani FW, Fahad HM. "Detection of the Level of Interleukin-8 in the Serum of Burn Patients by ELISA Technique." Archives of Razi Institute 2023. PMID: 38028842 ↩

[82] Sierawska O, et al. "Innate Immune System Response to Burn Damage-Focus on Cytokine Alteration." International journal of molecular sciences 2022. PMID: 35054900 ↩

[83] Mulder PPG, et al. "Persistent Systemic Inflammation in Patients With Severe Burn Injury Is Accompanied by Influx of Immature Neutrophils and Shifts in T Cell Subsets and Cytokine Profiles." Frontiers in immunology 2020. PMID: 33584717 ↩

[84] Bertram K, et al. "Insights from CTTACC: immune system reset by cellular therapies for chronic illness after trauma, infection, and burn." Cytotherapy 2024. PMID: 38506768 ↩

[85] Wu G, et al. "Can systemic inflammatory response syndrome score at admission predict clinical outcome in patients with severe burns?." Burns : journal of the International Society for Burn Injuries 2019. PMID: 30583937 ↩

[86] Ong YS, Samuel M, Song C. "Meta-analysis of early excision of burns." Burns : journal of the International Society for Burn Injuries 2006. PMID: 16414197 ↩

[87] Paratz JD, et al. "Burn resuscitation--hourly urine output versus alternative endpoints: a systematic review." Shock (Augusta, Ga.) 2014. PMID: 24978885 ↩

[88] Cocchi E, et al. "Skin grafting as a preventive strategy against infections in children with deep burns." Burns : journal of the International Society for Burn Injuries 2025. PMID: 40561806 ↩

[89] Yue HY, Wang Y, Zeng J, Jiang H, Li W. "Enteral glutamine supplements for patients with severe burns: A systematic review and meta-analysis." Chinese journal of traumatology = Zhonghua chuang shang za zhi 2024. PMID: 37460347 ↩

[90] Mayes T, Gottschlich MM, James LE, Allgeier C, Weitz J, Kagan RJ. "Clinical safety and efficacy of probiotic administration following burn injury." Journal of burn care & research : official publication of the American Burn Association 2015. PMID: 25559730 ↩

[91] Giudicissi A, et al. "[Acute kidney injury in severely burned patient: prevention and treatment]." Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 2023. PMID: 37179474 ↩

[92] Sjoberg F, et al. "The impact and validity of the Berlin criteria on burn-induced ARDS: Examining mortality rates, and inhalation injury influences. A single center observational cohort study." Burns : journal of the International Society for Burn Injuries 2024. PMID: 38777667 ↩

[93] Kraft R, Herndon DN, Finnerty CC, Shahrokhi S, Jeschke MG. "Occurrence of multiorgan dysfunction in pediatric burn patients: incidence and clinical outcome." Annals of surgery 2014. PMID: 23511841 ↩

[94] Soussi S, et al. "Risk Factors for Acute Mesenteric Ischemia in Critically Ill Burns Patients-A Matched Case-Control Study." Shock (Augusta, Ga.) 2019. PMID: 29561390 ↩

[95] Johnson RM, et al. "Early Dysregulation of Angiopoietin-1 and -2 as a Predictor of Mortality in Critically Ill Burn Patients." Journal of burn care & research : official publication of the American Burn Association 2026. PMID: 40899696 ↩